HELIXOR A série 4 sol inj amp 7 pce
7680562060396
CH-56206
L01CX
20.02.
1 / 3
google
Details
- Product number
- 5620606
- CPT
- -
- Packaging group
- 7
- Unit
- Ampulle(n)
- Composition
- extractum aquosum liquidum 400 mg ex viscum album (abietis) recens 20 mg, natrii chloridum, aqua q.s. ad solutionem pro 1 ml.
Articles (1)
Helixor A 20 mg, Injektionslösung (s.c.)
Injektionslösung
7
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
402.4 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
3.43 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 67.25
Specialties list
Yes
Generic
No
SL addition date:
01/05/2008
Authorization holder
Target BioScience AG
8803 Rüschlikon
Authorization information
- Swissmedic authorization number
- 56206
- Drug name
- Helixor A, Injektionslösung (s.c.)
- Galenic form
- LSINJ
- ATC Code
- L01CX
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 08/09/2006
- Authorization expiration date
- 31/12/9999
- IT number
- 20.02.
- Domain
- Human medicine
Packaging details
- Description (FR)
- HELIXOR A série 4 sol inj amp 7 pce
- Description (DE)
- HELIXOR A Serie 4 Inj Lös Amp 7 Stk
- Market launch
- 08/09/2006
- Narcotic (BTM)
- No